Medicine shortages – A study of community pharmacies in Finland
Tài liệu tham khảo
European Medicines Agency, 2011
Besancon, 2013
Morrison, 2011
McLaughlin, 2013, Effects on patient care caused by drug shortages: a survey, Journal of Managed Care Pharmacy, 19, 783, 10.18553/jmcp.2013.19.9.783
Baumer, 2004, National survey of the impact of drug shortages in acute care hospitals, American Journal of Health-System Pharmacy, 61, 2015, 10.1093/ajhp/61.19.2015
American Hospital Association, 2011
Institute for Safe Medication Practices (ISMP), 2010, National survey on drug shortages/ISMP survey on drug shortages, ISMP Medication Safety Alert, 15, 4
Becker, 2013, Impact of oncology drug shortages on patient therapy: unplanned treatment changes, Journal of Oncology Practice, 9, 122, 10.1200/JOP.2012.000799
Gundlapalli, 2013, Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists, Diagnostic Microbiology and Infectious Disease, 75, 256, 10.1016/j.diagmicrobio.2012.11.020
McBride, 2013, National survey on the effect of oncology drug shortages on cancer care, American Journal of Health-System Pharmacy, 70, 609, 10.2146/ajhp120563
Canadian Pharmacists Association, 2010
Kaakeh, 2011, Impact of drug shortages on U.S. health systems, American Journal of Health-System Pharmacy, 68, 1811, 10.2146/ajhp110210
Hunnisett-Dritz, 2012, Successful importation of cytarabine into the United States during a critical national drug shortage, American Journal of Health-System Pharmacy, 69, 1416, 10.2146/ajhp120113
Dolgin, 2011, NIH faces marching orders on orphan drug shortage, Nature Medicine, 17, 522, 10.1038/nm0511-522b
Kaiser, 2011, Medicine. Shortages of cancer drugs put patients, trials at risk, Science, 332, 523, 10.1126/science.332.6029.523
Mitka, 2011, FDA, US hospital and pharmacy groups report drug shortages a growing problem, The Journal of the American Medical Association, 306, 1069, 10.1001/jama.2011.1238
Roehr, 2011, FDA is to hold public meeting to discuss reasons for drug shortages, British Medical Journal, 343, 5650, 10.1136/bmj.d5650
EFPIA (European Federation of Pharmaceutical Industries and Associations), 2013
Pharma Industry Finland, Pharmaceutical Sales in Finland in 2013 http://www.pif.fi/Tiedostot/11%20wholesales%20year.pdf.
Pharma Industry Finland, Wholesale to pharmacies http://www.pif.fi/Tiedostot/13%20wholesales%20to%20pharmacies.pdf.
Association of Finnish Pharmacies, Apteekit numeroina. [Pharmacies in numbers] http://www.apteekkariliitto.fi/fi/apteekkitieto/apteekit-numeroina.html.
Association of Finnish Pharmacies, Annual review 2013 http://www.apteekkariliitto.fi/media/pdf/afp_annual_review_2013_web.pdf.
Peura, 2007
Pharma Industry Finland, Breakdown of pharmacy sales in 2012. http://www.pif.fi/Tiedostot/18%20pharmacy%20sales.pdf.
Pelkonen, 2010, s. 28
Ministry of Social Affairs and Health, Viitehintaryhmät ja viitehinnat. [Reference pricing system] http://www.stm.fi/stm/neuvottelukunnat/hila/viitehinta/viitehintaryhmat.
Timonen, 2013, Generic substitution in Finland: lessons learned during 2003–2008, Journal of Pharmacy and Health Research, 4, 165, 10.1111/jphs.12021
WHO Collaborating Centre for Drug Statistics Methodology, ATC – structure and principles. http://www.whocc.no/atc/structure_and_principles/.
2013
Joubert, 2010
Woodend, 2005, Drug shortages – risk or reality?, Canadian Pharmacists Journal/Revue des Pharmaciens du Canada, 138, 27, 10.1177/171516350513800105
Hartikainen-Herranen, 2005, s.69
Tiihonen, 2013, Apteekkifarmaseuttien käsitykset unettomuuden hoidosta ja unilääkkeiden käytöstä Suomessa, Dosis, 29, 75
2012
Tamro Suomi, 2013